Intelligence Β· Clinical Pipeline
R&D Pipeline Programs
ClinicalTrials.gov programs linked to pharma sponsors β phase, modality, and trial IDs for BD and competitive intelligence.
- Programs indexed
- 20,548
- Companies
- 1,769
- Drugs tracked
- 4,797
Quick answer
NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text β searchable for business development and competitive intelligence.
-
Sivelestat sodium
The First People's Hospital of Lianyungang
Aortic Dissection
1 trial -
Solifenacin Succinate
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Overactive Bladder
1 trial -
Specific Carbohydrate Diet
NORTHWEST BIOTHERAPEUTICS INC
Clostridium Difficile Infection
1 trial -
Spleen Invigorating and Weight Reducing Decoction
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Traditional Chinese Medicine Treatment
1 trial -
Stereotactic body radiotherapy (SBRT)
Xiyuan Hospital of China Academy of Chinese Medical Sciences
HSCT
1 trial -
Suanzaoren Decoction and Huanglian Wendan Decoction
The First People's Hospital of Lianyungang
Traditional Chinese Medicine
1 trial -
Subconjunctival dexamethasone and general anesthesia
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Cataract
1 trial -
Surgery combined with Target-reduction intensity-modulated radiotherapy
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Nasopharyngeal Carcinoma
1 trial -
T cell injection targeting CD7 chimeric antigen receptor
The First People's Hospital of Lianyungang
T-ALL
1 trial -
T, 260 mg/m2, paclitaxel for injection (albumin-bound)
The First People's Hospital of Lianyungang
Breast Cancer
1 trial -
TEA plus GDMT
The First People's Hospital of Lianyungang
Heart Failure With Reduced Ejection Fraction
1 trial -
TRF (Tocotrienol-rich-fraction)
United Therapeutics Europe Ltd
End Stage Renal Disease
1 trial -
Tadalafil 2.5Mg Tab
Hospital Authority, Hong Kong
Erectile Dysfunction
1 trial -
Tegoprazan-amoxicillin dual therapy
The First People's Hospital of Lianyungang
Helicobacter Pylori Infection
1 trial -
Topical compound tripterygium
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Active Rheumatoid Arthritis
1 trial -
Ulinastatin and Thymosin Ξ±1
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Aortic Dissection
1 trial -
Unfractionated heparin
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Primary PCI
1 trial -
Urinary kallidinogenase for injection
The First People's Hospital of Lianyungang
Acute Ischemic Stroke
1 trial -
Urine Culture
United Therapeutics Europe Ltd
Urinary Tract Infection
1 trial -
Virtual Reality (VR) Contrast Function Test
Apellis Europe B.V.
Age-Related Macular Degeneration
1 trial -
Vitamin D supplement
BRIGHT MINDS BIOSCIENCES INC.
HIV Infections
1 trial -
Vonoprazan+amoxicillin+doxycycline+bismuth for 14 days
The First People's Hospital of Lianyungang
Helicobacter Pylori Infection
1 trial -
Within-subjects (MDMA)
BRIGHT MINDS BIOSCIENCES INC.
Drug Addiction
1 trial -
Xiangsha Liujunzi granules
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Functional Dyspepsia
1 trial
Frequently asked questions
What is the NovaPharmaNews pipeline directory?
It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1β3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.
Where does pipeline data come from?
Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync β verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.
How do I find pipeline programs by company or phase?
Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.
Data attribution and licensing: Data sources